Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03725098 · ClinicalTrials.gov registry record · NA
Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations
A NA study of Cardiothoracic Surgery, sponsored by Biom'Up France SAS.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 4
- Study locations
NCT03725098: Completed NA study of Cardiothoracic Surgery, sponsored by Biom'Up France SAS.
NCT03725098 is a NA study of Cardiothoracic Surgery that has completed, run by Biom'Up France SAS. The registered enrollment target is 105 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03725098, a NA study of Cardiothoracic Surgery, has completed, sponsored by Biom'Up France SAS.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the performance of HEMOBLAST™ compared to FLOSEAL in cardiothoracic operations.
Primary Outcome
The primary endpoint of this study is the superiority of HEMOBLAST™ relative to FLOSEAL for the proportion of subjects reaching hemostasis within 3 minutes.
Conditions Studied
Interventions
- DEVICE HEMOBLAST Bellows
- DEVICE FLOSEAL
Study Locations (4)
California
- University of California Los Angeles - Los Angeles
Hawaii
- Kaiser Permanente Moanalua Medical Center - Honolulu
Louisiana
- Ochsner Clinic Foundation - New Orleans
Texas
- Houston Methodist - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2019-06-28 |
| Phase | NA |
What the finished NCT03725098 record still lists
NCT03725098 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Cardiothoracic Surgery appearing as the primary indexed condition, and to 2 interventions - of which HEMOBLAST Bellows is the first listed.
NCT03725098 reports a single indexed study location in California, Hawaii, Louisiana.
Frequently Asked Questions
What is clinical trial NCT03725098 about?
NCT03725098 is a clinical study titled "Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations". The purpose of this study is to evaluate the performance of HEMOBLAST™ compared to FLOSEAL in cardiothoracic operations.
What is the current status of trial NCT03725098?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2019-03-01. Estimated completion is 2019-06-28.
What conditions does trial NCT03725098 study?
This clinical trial studies the following conditions: Cardiothoracic Surgery.
What interventions are being tested in trial NCT03725098?
The interventions under investigation include: HEMOBLAST Bellows (DEVICE), FLOSEAL (DEVICE).
Who is sponsoring clinical trial NCT03725098?
This trial is sponsored by Biom'Up France SAS, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03725098 being conducted?
This trial has 4 study locations across California, Hawaii, Louisiana, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03725098's enrollment target sits among peer trials
105 834th of 2000 higher than 1,165 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI